Abecasis
Goncalo Abecasis, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20090203001 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION - The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers (e.g., polymorphisms and/or haplotypes) for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications. | 08-13-2009 |
20110014716 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION - The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications. | 01-20-2011 |
20120135884 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION - The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications. | 05-31-2012 |
20130266937 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION - The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers (e.g., polymorphisms and/or haplotypes) for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications. | 10-10-2013 |
20140322712 | DIAGNOSIS AND TREATMENT OF MACULAR DEGENERATION - The present invention relates generally to biomarkers for macular degeneration. In particular, the biomarkers and related compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications. | 10-30-2014 |
Goncalo Rocha Abecasis, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20110046202 | METHOD FOR TESTING A SUBJECT THOUGHT TO HAVE OR TO BE PREDISPOSED TO ASTHMA - The present invention concerns a method of testing a subject thought to have or be predisposed to having asthma, allergy, atopic disease or atopic sensitization, which comprises the step of analyzing a biological sample from said subject for (i) detecting the presence of a mutation associated with the over-expression of the ORMDL3 gene, and/or (ii) analyzing the expression of the ORMDL3 gene; a use, for treating and/or preventing asthma, allergy, atopic disease or atopic sensitization in a subject, of a compound which specifically inhibits the expression of the ORMDL3 gene; and an in vitro method of selecting a compound, which can be useful for treating asthma, allergy, atopic disease or atopic sensitization, characterized in that said method comprises the steps of: (a) obtaining a cell expressing the ORMDL3 gene, (b) contacting said cell with at least one compound, (c) comparing the expression of the ORMDL3 gene in the cell between the steps a) and b), and (d) selecting the compound, which induces a lower level of expression of the ORMDL3 gene in the cell contacted to that compound. | 02-24-2011 |
Yaki Abecasis, Herzelia IL
Patent application number | Description | Published |
---|---|---|
20150180533 | COMMUNICATION SYSTEM AND A METHOD FOR MITIGATING LEAKAGE SIGNALS - A communication system that includes a transmit antenna, a radio frequency (RF) phase shifting module, an RF combiner, a first receive antenna and a second receive antenna; wherein the first and second receive antennas are located at a same distance from the transmit antenna; wherein the first and second receive antennas are arranged to receive first and second leakage signals resulting from a transmission of RF radiation by the transmit antenna; wherein the RF phase shifting module is configured to receive signals from the first and second receive antennas, to phase shift signals from at least one of first and second receive antennas to provide intermediate RF signals; wherein the phase shift caused by the RF phase shifting module introduces a destructive phase shift between the first and second leakage signals; wherein the RF combiner is configured to add the intermediate RF signals to provide combined RF signals. | 06-25-2015 |